Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.205
-0.015 (-1.23%)
At close: Jul 24, 2026, 4:00 PM EDT
1.200
-0.005 (-0.41%)
After-hours: Jul 24, 2026, 7:11 PM EDT
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 118 employees as of March 31, 2026. The number of employees decreased by 58 or -32.95% compared to the same quarter last year.
Employees
118
Change
-58
Growth
-32.95%
Revenue / Employee
$189,246
Profits / Employee
-$727,864
Market Cap
45.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 118 | -58 | -32.95% |
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Mereo BioPharma Group | 39 |
| INmune Bio | 21 |
| Filana Therapeutics | 20 |
| Edesa Biotech | 17 |
| Dyadic International | 5 |
MGX News
- 11 days ago - Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio - GlobeNewsWire
- 19 days ago - Metagenomi transferred with a Buy at Chardan - TheFly
- 6 weeks ago - Metagenomi Therapeutics Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 7 weeks ago - Metagenomi Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Metagenomi price target lowered to $9 from $12 at Wells Fargo - TheFly
- 2 months ago - Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - GlobeNewsWire